[Optimization of digitalis therapy in clinical practice].

Area of Science:

• Cardiology
• Pharmacology

Background:

• Cardiac glycosides, including digoxin, have seen reduced use in heart failure patients.
• Published studies present contradictory findings regarding digoxin's efficacy and safety.
• This has led to uncertainty about its role in managing heart failure with sinus rhythm and atrial fibrillation.

Purpose of the Study:

• To impartially analyze existing literature on cardiac glycosides.
• To reflect modern understanding of cardiac glycoside mechanisms and pharmacokinetics.
• To explore strategies for optimizing digitalis therapy in clinical practice.

Main Methods:

• Systematic review and meta-analysis of published studies.
• Analysis of pharmacokinetic and pharmacodynamic data.
• Evaluation of clinical trial outcomes related to digoxin use.

Main Results:

• Evidence remains divided on whether digoxin improves outcomes or increases mortality/hospitalizations.
• Pharmacokinetic variability influences digoxin's therapeutic window.
• Optimizing digitalis therapy requires careful patient selection and monitoring.

Conclusions:

• A balanced perspective on digoxin's benefits and risks is necessary.
• Further research may clarify optimal use cases for digitalis in heart failure.
• Personalized approaches to digitalis therapy are crucial for effective patient management.